Annals of medicine · 2026-11-03 · 综述
Stem cell transplantation holds therapeutic promise for stroke, yet its clinical translation is hindered by unresolved challenges in administration routes, timing, and poor cell engraftment and survival. This is a narrative (non-systematic) review. Registered clinical studies were identified in ClinicalTrials.gov, the European Union Clinical Trials Register and the Chinese Clinical Trial Registry, and were supplement…
(中文解读待补写)
🔗 打开原文
Meng Q, Deng H, Zhang Z 等
本文摘自《每日前沿研究简报 · 2026-11-05》「发育·再生·干细胞」。本内容仅用于研究信息整理与科普交流,不构成医疗建议。

发表评论 取消回复